HIV is a virus that attacks the immune system and weakens your ability to fight infections and disease. It is most commonly caught by having sex without a condom. It can also be passed on by sharing infected needles and other injecting equipment, and from an HIV-positive mother to her child during pregnancy, birth and breastfeeding.
HIV stands for human immunodeficiency virus. The virus attacks the immune system and weakens your ability to fight infections and disease. There is no cure for HIV, but there are treatments to enable most people infected to live a long and healthy life.
AIDS is the final stage of HIV infection when your body can no longer fight life-threatening infections. With early diagnosis and effective treatment, most people with HIV will not go on to develop AIDS.
Short pulse anti retroviral therapy at HIV seroconversion
Short pulse anti retroviral therapy at HIV seroconversion (SPARTAC) is the largest randomised control trial ever undertaken in recent HIV infection. The study ran between 2003 and 2011 across eight countries. The aim of SPARTAC was to examine whether treating people recently infected with HIV with anti-HIV drugs for a short period of time could slow down the damage caused by HIV to the immune system and consequently delay the need to start long-term treatment.
HPTN 071 PopART
Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART) is a research study that will determine the impact of a package of HIV prevention interventions on community-level HIV incidence. These prevention interventions include universal household voluntary HIV counseling and testing, linkage of HIV infected individuals to care and early initiation of antiretroviral therapy (ART) for all those testing HIV-positive.